Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,808 followers.

RT @TheveninLab: Our latest work with our good colleague Jörg Müller @UniJena confirming our previous results on the effect of PTPRJ transm…

28 Nov 2022

Reply Repost Favourite

Our latest work with our good colleague Jörg Müller @UniJena confirming our previous results on the effect of PTPRJ transmembrane interactions on RTK substrate phosphorylation and downstream signaling. This time with FLT3! @LehighChem @LehighResearch

24 Nov 2022

Reply Repost Favourite

Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD https://t.co/HmJvI3vITN https://t.co/6MZa6AnhN4

14 Nov 2022

Reply Repost Favourite

New research: Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD: The receptor protein tyrosine phosphatase (RPTP) PTPRJ (also known as DEP-1) has been identified as a negative… https://t.co/KTJt

14 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.